All Type of News
Rapid approval of drugs eyed
The Korea Food and Drug Administration said Thursday that it will revise the screening procedures for new rules as part of its efforts to provide better support for the domestic drug makers to develop specific drugs, ...
Pharmaceutical companies call for more deregulation
Domestic drug manufacturers have asked the government to ease drug related regulations, such as scope of toll manufacturing and bioequivalence, and heavy fines.
In a recent meeting with officials from the Korea Foo...
Green Cross to co-promote Ipsen’s Diphereline
Green Cross Corp. said Thursday that it has signed an agreement with Ipsen Korea to co-market Diphereline (triptorelin) in Korea.
Diphereline is triptorelin, a decapeptide analogue of GnRH (Gonadotrophin Releasing ...
Lilly Korea changes package of Cialis 20 mg pills
Cialis is a popular impotence drug and has achieved remarkable success, but now fake Cialis sale online is prompting Lilly Korea to change the package of Cialis 20 mg pills as part of efforts to distinguish Cialis bet...
KFDA to go all-outs to support drug export
Korea aims to achieve $10 billion in annual drug export volume by 2015 by undertaking five core projects, a chief of the Korea Food Drug Administration said Wednesday.
In a brief gathering on February 16, the KFDA ...
Hospitals overcharge 4.8 billion won
Patients received about 4.8 billion won in medical fee refunds last year because some hospitals overcharged for health insurance coverage, health authorities said recently.
The Health Insurance Review & Assessment...
KPMA to set up biotech medicine department
The Korea Pharmaceutical Manufacturers Association has a plan to establish a new biotech medicine department as part of its efforts to help globalize the domestic biotech medicines industry.
The department will hav...
Medison seeking to consolidate global position
New CEO Bang Sang-won of Medison, a Seoul-based ultrasonic diagnostic equipment manufacturer, has recently unveiled his plan to grow the company into the third-largest player in the world diagnostic ultrasound system ...
BMS’s Baraclude increase market share
The US based Bristol Myers Squibb’s Baraclude (entecavir) for treatment of hepatitis B accounted for about 50 percent of the sector’s domestic sales last year, an industry report showed yesterday.
Just within to tw...
GMP standards to be simplified
If a persons to change and/or transfer a drug manufacturing site, the GMP (Good Manufacturing Practice) evaluation criteria for a corresponding drug will be simplified, according to the Korea Food and Drug Administrat...
